Development Level

Tclin 2 | 613
Tbio 1 | 11,445
Tchem 1 | 1,598

IMPC Phenotype

corneal opacity 1 | 32

Disease

Anemia 4 | 365
Cancer 4 | 2,499
Carcinoma 4 | 11,493
Pruritus 4 | 58
Arterial thrombosis 3 | 9
Bleeding tendency 3 | 37
Chest Pain 3 | 38
Essential thrombocythemia 3 | 10
Familial thrombocytosis 3 | 3
Headache 3 | 37
Hyperhidrosis disorder 3 | 81
Immune system cancer 3 | 140
Increased number of platelets 3 | 14
Increased sweating 3 | 81
Myeloproliferative disease 3 | 16
Paresthesia 3 | 32
Peripheral arterial occlusive disease 3 | 4
Peripheral vascular insufficiency 3 | 4
Polycythemia vera 3 | 27
Somatic mutation 3 | 61
Splenomegaly 3 | 190
Sweating 3 | 81
THROMBOCYTHEMIA 1 3 | 3
THROMBOCYTHEMIA 2 3 | 3
THROMBOCYTHEMIA 3 3 | 3
Thrombocythemia, Essential 3 | 12
Thrombocytopenia 3 | 197
Thrombocytosis 3 | 38
Transient Cerebral Ischemia 3 | 25
Venous Thrombosis 3 | 47
vascular disease occlusive 3 | 4
Abdominal Pain 2 | 98
Acquired scoliosis 2 | 281
Acute blood cancer 2 | 6
Acute leukemia 2 | 15
Amaurosis Fugax 2 | 8
Angina Pectoris 2 | 32
Arthralgia 2 | 90
Arthritis 2 | 290
Autoimmune thrombocytopenic purpura 2 | 13
Bleeding time prolonged 2 | 31
Brain Ischemia 2 | 110
Cardiomyopathies 2 | 110
Coarse facial features 2 | 108
Colitis, Ulcerative 2 | 59
Crohn's disease 2 | 321
Curvature of spine 2 | 282
Decreased platelet count 2 | 111
Dizziness 2 | 26
Ecchymosis 2 | 66
Epistaxis 2 | 43
Fatigue 2 | 182
Fever 2 | 138
Gingival Hemorrhage 2 | 18
Hepatomegaly 2 | 285
Hypertensive disease 2 | 292
Hypoplastic myelodysplasia 2 | 18
Increase in blood pressure 2 | 119
Increased megakaryocyte count 2 | 6
Increased tendency to bruise 2 | 66
Inflammation 2 | 120
Leukemia, Myelocytic, Acute 2 | 120
Leukemia, Myeloid, Acute 2 | 105
Liver Neoplasms, Experimental 2 | 59
Liver disease 2 | 237
Lymphoid leukemia 2 | 160
MYELODYSPLASTIC SYNDROME 2 | 53
Myelofibrosis 2 | 14
Myocardial Infarction 2 | 151
Obesity 2 | 678
Platelet morphology abnormal 2 | 9
Portal hypertension 2 | 20
Primary Myelofibrosis 2 | 5
Prostatic Neoplasms 2 | 495
Purpura 2 | 43
Respiratory Insufficiency 2 | 132
Respiratory function loss 2 | 121
Rheumatoid arthritis 2 | 1,191
Short stature 2 | 531
Thickened facial skin with coarse facial features 2 | 108
Tinnitus 2 | 19
Uterine Cervical Neoplasms 2 | 26
Vertigo 2 | 29
Weight decreased 2 | 103
lung cancer 2 | 4,740
medulloblastoma 2 | 720
osteosarcoma 2 | 7,950
ovarian cancer 2 | 8,520
thrombocytopenia-absent radius syndrome 2 | 6
ulcerative colitis 2 | 1,819
Brain hemorrhage 1 | 14
Cardiomegaly 1 | 116
Cerebral Hemorrhage 1 | 42
Enophthalmos 1 | 75
Generalized osteopenia 1 | 99
Hypertension, Portal 1 | 22
Osteopenia 1 | 99
Polycythemia 1 | 25
Sunken eyes 1 | 63
non-small cell lung carcinoma 1 | 317

Tissue

Blood and immune system 4 | 16,909
Cardiovascular System 4 | 15,192
Digestive Tract 4 | 17,369
Endocrine System 4 | 18,159
Female tissues 4 | 17,400
Liver and Pancreas 4 | 16,750
Male tissues 4 | 17,142
Nervous System 4 | 16,725
Respiratory system 4 | 16,393
Skin and soft tissues 4 | 17,230
Urinary Tract 4 | 16,678

Target Family

Non-IDG 2 | 12,091
Kinase 1 | 634
Transcription Factor 1 | 1,400

PathwayCommons: inoh Pathway

http://pathwaycommons.org/pc2/... 4 | 4
http://pathwaycommons.org/pc2/... 236 | 236
http://pathwaycommons.org/pc2/... 235 | 235
http://pathwaycommons.org/pc2/... 233 | 233
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 224 | 224
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 223 | 223
http://pathwaycommons.org/pc2/... 183 | 183
http://pathwaycommons.org/pc2/... 178 | 178
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 173 | 173
http://pathwaycommons.org/pc2/... 123 | 123
http://pathwaycommons.org/pc2/... 96 | 96
http://pathwaycommons.org/pc2/... 85 | 85
http://pathwaycommons.org/pc2/... 63 | 63
http://pathwaycommons.org/pc2/... 60 | 60
http://pathwaycommons.org/pc2/... 58 | 58
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 56 | 56
http://pathwaycommons.org/pc2/... 55 | 55
http://pathwaycommons.org/pc2/... 51 | 51
http://pathwaycommons.org/pc2/... 49 | 49
http://pathwaycommons.org/pc2/... 48 | 48
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 47 | 47
http://pathwaycommons.org/pc2/... 45 | 45
http://pathwaycommons.org/pc2/... 44 | 44
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 43 | 43
http://pathwaycommons.org/pc2/... 42 | 42
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 40 | 40
http://pathwaycommons.org/pc2/... 38 | 38
http://pathwaycommons.org/pc2/... 37 | 37
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 36 | 36
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 35 | 35
http://pathwaycommons.org/pc2/... 34 | 34
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 30 | 30
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 29 | 29
http://pathwaycommons.org/pc2/... 28 | 28
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 27 | 27
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 24 | 24
http://pathwaycommons.org/pc2/... 22 | 22
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 21 | 21
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 20 | 20
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 19 | 19
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 18 | 18
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 17 | 17
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 16 | 16
http://pathwaycommons.org/pc2/... 15 | 15

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Thrombopoietin THPO Tbio Non-IDG -3.23551 1632.3 440
Thrombopoietin receptor MPL Tclin Non-IDG -2.74303 582.0 186
Signal transducer and activator of transcription 3 STAT3 Tchem Transcription Factor -3.81500 6459.7 1749
Tyrosine-protein kinase JAK2 JAK2 Tclin Kinase -3.54037 3339.7 801